About this trial
Small bowel capsule endoscopy is the main diagnostic standard for small bowel bleeding. This study investigates the detection rate of small bowel bleeding in capsule endoscopy and further endoscopic treatment in a prospective and retrospective cohort.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
suspicion of gastrointestinal bleeding in the small bowel undetected by gastroscopy and colonoscopy
informed consent
Disqualifiers
contraindications for small bowel capsule endoscopy (e.g. stenosis)
Trial population
Patients who present with gastrointestinal bleeding undetected in gastroscopy or colonoscopy will be included in this cohort study. In these patients bleeding in the small bowel is suspected and they are allocated to a diagnostic assessment with small bowel capsule endoscopy.
Trial design
Cohort
Prospective
Treatments tested in this trial
Small bowel capsule endoscopy
DevicePatients with gastrointestinal bleeding receive small bowel capsule endoscopy after bleeding could not be located in gastroscopy or colonoscopy.
Treatment groups
Trial outcomes
Primary outcomes
Prevalence of small bowel bleeding detected during small bowel capsule endoscopy
Detection of bleeding during small bowel capsule endoscopy
Secondary outcomes
Prevalence of vascular lesions as source of bleeding
Detection of vascular lesions angiodysplasia) as source of bleeding
Prevalence of inflammatory lesions as source of bleeding
Detection of inflammatory lesions as source of bleeding
Prevalence of tumor lesions as source of bleeding
Detection of tumor lesions as source of bleeding
Complications of small bowel capsule endoscopy
Complications of small bowel capsule endoscopy
Sponsors and contacts
Click on the lead sponsor to view all of their trials.